OFIX Overview

Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.

Wall Street analysts forecast OFIX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OFIX is21.33 USD with a low forecast of 18.00 USD and a high forecast of 24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Orthofix Medical Inc revenue for the last quarter amounts to 219.91M USD, increased 1.97

Orthofix Medical Inc. EPS for the last quarter amounts to -0.06 USD, decreased -92.00

Orthofix Medical Inc (OFIX) has 1605 emplpoyees as of April 20 2026.

Today OFIX has the market capitalization of 510.24M USD.